Milestone Pharmaceuticals (MIST)
(Delayed Data from NSDQ)
$1.71 USD
-0.04 (-2.29%)
Updated May 24, 2024 03:59 PM ET
After-Market: $1.72 +0.01 (0.58%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth A Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/08/2024
Time: -- |
6/2024 | $-0.19 | 0.00% |
Earnings Summary
For their last quarter, Milestone Pharmaceuticals (MIST) reported earnings of -$0.21 per share, beating the Zacks Consensus Estimate of $-0.26 per share. This reflects a positive earnings surprise of 19.23%. Look out for MIST's next earnings release expected on August 08, 2024. For the next earning release, we expect the company to report earnings of -$0.19 per share, reflecting a year-over-year increase of 48.65%.
Earnings History
Price & Consensus
Zacks News for MIST
Down -43.64% in 4 Weeks, Here's Why Milestone Pharmaceuticals (MIST) Looks Ripe for a Turnaround
MIST: What are Zacks experts saying now?
Zacks Private Portfolio Services